Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Annual Review of Medicine|January 15, 2015
Targeting HER2 for the treatment of breast cancerMothaffar F Rimawi, Rachel Schiff, C Kent Osborne
Breast Cancer Research and Treatment|September 13, 2021
Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancerJason A Mouabbi, C Kent Osborne, Rachel Schiff, et al.
Nature Reviews. Clinical Oncology|December 15, 2019
Towards personalized treatment for early stage HER2-positive breast cancerKristina Goutsouliak, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, et al.
Cancer|January 19, 2010
Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomesMothaffar F Rimawi, Priya B Shetty, Heidi L Weiss, et al.
Advances in Experimental Medicine and Biology|January 17, 2025
HER2-Positive Breast Cancer Treatment and ResistanceJamunarani Veeraraghavan, Carmine De Angelis, Carolina Gutierrez, et al.
Breast (Edinburgh, Scotland)|July 9, 2017
De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistanceJamunarani Veeraraghavan, Carmine De Angelis, Jorge S Reis-Filho, et al.
Breast Cancer Research and Treatment|February 21, 2014
Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistanceGladys Morrison, Xiaoyong Fu, Martin Shea, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Resistance to Anti-HER2 Therapies in Breast CancerMothaffar F Rimawi, Carmine De Angelis, Rachel Schiff
Breast Cancer Research : BCR|September 3, 2011
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinibCatherine Huang, Catherine C Park, Susan G Hilsenbeck, et al.
Pageof 18